Patent · US Active

Trispecific antibodies specific for HER2 and a blood brain barrier receptor and methods of use

US12331134B2 · kind B2 · utility

0Cited by

44References

19Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Christian Klein · Iffeldorf, DE
Julia E. Krueger · Deerfield, US
Ekkehard Moessner · Kreuzlingen, CH
Jens Niewoehner · Munich, DE

Key dates

Filing date	Jun 10, 2022
Grant date	Jun 17, 2025
Priority date	—
Expiry date	Mar 3, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to trispecific antibodies binding to HER2 and a blood-brain barrier receptor (BBB-R), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.